Rydex Series Trust Health Care Fund

3 / 5 Stars
2 2 5 3 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
A+ (Buy)

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Rydex Funds funds

See full Health rankings

See more fund rankings


The fund has returned 43.91 percent over the past year, 22.18 percent over the past three years, 23.80 percent over the past five years, and 9.21 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 9.4%
1 Year 43.9%
3 Years (Annualized) 22.2%
5 Years (Annualized) 23.8%
10 Years (Annualized) 9.2%

See more RYHIX performance


The investment seeks capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Health Care Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It will invest to a significant extent in the securities of Health Care Companies that have small to mid-sized capitalizations. The fund also may purchase American Depositary Receipts ("ADRs") to gain exposure to foreign Health Care Companies and U.S. government securities. It is non-diversified.


Fees are Low compared to funds in the same category.
Rydex Series Trust Health Care Fund has an expense ratio of 1.35 percent.

See more RYHIX fees


Risk is Below Average compared to funds in the same category according to Morningstar.

See more RYHIX risk